Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Pal S, Graves H, Ohsawa R, Huang T-, Wang P, Harmacek L, et al. The Commercial Antibodies Widely Used to Measure H3 K56 Acetylation Are Non-Specific in Human and Drosophila Cells. PLoS One. 2016;11(5):e0155409.

Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, et al. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016;30(1):183.

Wells J, Ozerdem U, Scognamiglio T, Hoda SA. Invasive Mammary Adenoid Cystic Carcinoma with an Intraductal Component. Breast J. 2016;22(2):233-4.

Lu D, Sinnott JA, Valdimarsdóttir U, Fang F, Gerke T, Tyekucheva S, et al. Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer. Clin Cancer Res. 2016;22(3):765-772.

Winer A, Janosky M, Harrison B, Zhong J, Moussai D, Siyah P, et al. Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study. Mol Cancer Ther. 2016;15(10):2370-2377.

Quinley KE, Chen H-, Yang HS, Lynch KL, Olson KR. Clenbuterol causing non-ST-segment elevation myocardial infarction in a teenage female desiring to lose weight: case and brief literature review. Am J Emerg Med. 2016;34(8):1739.e5-7.

Cantalupo A, Di Lorenzo A. S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis. J Pharmacol Exp Ther. 2016;358(2):359-70.

Testo N, Olson LC, Subramaniyam S, Hanson T, Magro CM. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas. Am J Dermatopathol. 2016;38(10):769-74.

Mullane SA, Werner L, Guancial EA, Lis RT, Stack EC, Loda M, et al. Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma. Clin Genitourin Cancer. 2016;14(4):352-9.

Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, et al. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016;57(7):1731-4.